FDA to phase out animal testing with AI and lab-based models
FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…
CertaraApril 11, 2025
eCTD 4.0: When & Where it will be Implemented Next
Associate Director, Regulatory Operations Over 20 years of experience in eCTD submissions and FDA interactions.…
CertaraApril 11, 2025
Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling
Discover how predictive modeling and model-informed formulation development (MIFD) are accelerating drug development. Learn from…
CertaraApril 11, 2025
Tackling Affordability with Direct-to-Patient Sales
April 11, 2025 Accessing affordable healthcare is one of the biggest challenges U.S. patients face.…
CertaraApril 11, 2025
Write Quicker PBPK Reports with the Simcyp Report Assistant
April 11, 2025 Writing a report for PBPK models can be an onerous process, especially…
CertaraApril 11, 2025
Delivering DSUR Excellence for Multinational Biopharma
A global leader in immuno-oncology approached us for support with over 50 simple to complex…
CertaraApril 11, 2025
Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications
Vice President, MBMA Capability Lead, Certara Drug Development Solutions Matt advances the integration of published…
CertaraApril 10, 2025
FDA plans to phase out animal testing requirements
Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…
CertaraApril 10, 2025
